| Citation: |
WANG Lingxiao, WANG Yingjia, YANG Jian, LI Yaoping. Research Progress on Mechanism of Mitochondrial DNA in Occurrence and Development of Digestive System Malignant Tumors[J]. Cancer Research on Prevention and Treatment, 2022, 49(8): 838-842. DOI: 10.3971/j.issn.1000-8578.2022.22.0542
|
Mitochondrial DNA (mt-DNA) is an important carrier of extranuclear genetic information. Recent research results show that mt-DNA is closely related to the occurrence and metastasis of various malignant tumors, and can be used for early diagnosis and targeted therapy of cancer. Therefore, further research on the mechanism of mt-DNA in digestive system malignant tumors has important clinical significance for screening and identifying tumor molecular markers for anti-tumor drug targets, cancer diagnosis and prognosis analysis. This article reviews the research progress on the potential relationship, clinical application and therapeutic targets of mt-DNA and digestive system malignancies.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Bas U, Bostwick AM, Das K, et al. Structure, mechanism, and regulation of mitochondrial DNA transcription initiation[J]. J Biol Chem, 2020, 295(52): 18406-18425. doi: 10.1074/jbc.REV120.011202
|
| [2] |
Wallace DC, Chalkia D. Mitochondrial DNA Genetics and the Heteroplasmy Conundrum in Evolution and Disease[J]. Cold Spring Harb Perspect Biol, 2013, 5(11): a021220. doi: 10.1101/cshperspect.a021220
|
| [3] |
Weinberg SE, Sena LA, Chandel NS, et al. Mitochondria in the Regulation of Innate and Adaptive Immunity[J]. Immunity, 2015, 42(3): 406-417. doi: 10.1016/j.immuni.2015.02.002
|
| [4] |
Cinat D, Coppes RP, Barazzuol L. DNA Damage-Induced Inflammatory Microenvironment and Adult Stem Cell Response [J]. Front Cell Dev Biol, 2021, 9: 729136. doi: 10.3389/fcell.2021.729136
|
| [5] |
Singh G, Pachouri UC, Khaidem DC, et al. Mitochondrial DNA Damage and Diseases[J]. F1000Res, 2015, 4: 176. doi: 10.12688/f1000research.6665.1
|
| [6] |
Chihara N, Amo T, Tokunaga A, et al. Mitochondrial DNA Alterations in Colorectal Cancer Cell Lines[J]. J Nippon Med Sch, 2011, 78(1): 13-21. doi: 10.1272/jnms.78.13
|
| [7] |
Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease[J]. Ann Neurol, 2015, 77(5): 753-759. doi: 10.1002/ana.24362
|
| [8] |
Yan C, Duanmu X, Zeng L, et al. Mitochondrial DNA: Distribution, Mutations, and Elimination[J]. Cells, 2019, 8(4): 379. doi: 10.3390/cells8040379
|
| [9] |
Dong LF, Kovarova J, Bajzikova M, et al. Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells[J]. Elife, 2017, 6: e22187. doi: 10.7554/eLife.22187
|
| [10] |
Masuike Y, Tanaka K, Makino T, et al. Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis[J]. PLos One, 2018, 13(2): e0193159. doi: 10.1371/journal.pone.0193159
|
| [11] |
Lin CS, Huang YY, Pan SC, et al. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUVmax of FDG-PET scan in esophageal squamous cell carcinoma[J]. Mitochondrion, 2019, 47: 54-63. doi: 10.1016/j.mito.2019.05.001
|
| [12] |
Liu ZW, Guo ZJ, Chu AL, et al. High incidence of coding gene mutations in mitochondrial DNA in esophageal cancer[J]. Mol Med Rep, 2017, 16(6): 8537-8541. doi: 10.3892/mmr.2017.7663
|
| [13] |
Zhuang X, Chen Y, Wu Z, et al. Mitochondrial miR-181a-5p promotes glucose metabolism reprogramming in liver cancer by regulating the electron transport chain[J]. Carcinogenesis, 2020, 41(7): 972-983. doi: 10.1093/carcin/bgz174
|
| [14] |
Yin PH, Wu CC, Lin JC, et al. Somatic mutations of mitochondrial genome in hepatocellular carcinoma[J]. Mitochondrion, 2010, 10(2): 174-182. doi: 10.1016/j.mito.2009.12.147
|
| [15] |
Lin YH, Chu YD, Lim SN, et al. Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics[J]. Int J Mol Sci, 2021, 22(3): 1119. doi: 10.3390/ijms22031119
|
| [16] |
Yin C, Li DY, Guo X, et al. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis[J]. Ann Oncol, 2019, 30(6): 953-962. doi: 10.1093/annonc/mdz105
|
| [17] |
Campo D, Nayak V, Srinivasamoorthy G, et al. Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma[J]. BMC Med Genomics, 2019, 12(Suppl 4): 74.
|
| [18] |
Moro L. Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers[J]. Int J Mol Sci, 2021, 22(18): 9692. doi: 10.3390/ijms22189692
|
| [19] |
Chaturvedi A, Kumar V, Gupta S. Molecular Oncology of Gall Bladder Cancer[J]. Indian J Surg Oncol, 2021, 12(Suppl 1): 57-64.
|
| [20] |
Tang M, Baez S, Pruyas M, et al. Mitochondrial DNA mutation at the D310 (displacement loop) mononucleotide sequence in the pathogenesis of gallbladder carcinoma[J]. Clin Cancer Res, 2004, 10(3): 1041-1046. doi: 10.1158/1078-0432.CCR-0701-3
|
| [21] |
Wang B, Qiao L, Wang Y, et al. Mitochondrial DNA D-loop lesions with the enhancement of DNA repair contribute to gastrointestinal cancer progression[J]. Oncol Rep, 2018, 40(6): 3694-3704.
|
| [22] |
Rodrigues-Antunes S, Borges BN. Alterations in mtDNA, gastric carcinogenesis and early diagnosis[J]. Mitochondrial DNA A DNA Mapp Seq Anal, 2019, 30(2): 226-233.
|
| [23] |
Han CB, Ma JM, Xin Y, et al. Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significance[J]. World J Gastroenterol, 2005, 11(1): 31-35. doi: 10.3748/wjg.v11.i1.31
|
| [24] |
Lin YH, Lim SN, Chen CY, et al. Functional Role of Mitochondrial DNA in Cancer Progression[J]. Int J Mol Sci, 2022, 23(3): 1659. doi: 10.3390/ijms23031659
|
| [25] |
Jung SJ, Cho JH, Park WJ, et al. Telomere length is correlated with mitochondrial DNA copy number in intestinal, but not diffuse, gastric cancer[J]. Oncol Lett, 2017, 14(1): 925-929. doi: 10.3892/ol.2017.6197
|
| [26] |
Chang TC, Lee HT, Pan SC, et al. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma[J]. Int J Mol Sci, 2022, 23(3): 1857. doi: 10.3390/ijms23031857
|
| [27] |
Bao XT, Zhang JH, Huang GM, et al. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development[J]. Cell Death Dis, 2021, 12(2): 215. doi: 10.1038/s41419-021-03505-1
|
| [28] |
Jin EH, Sung JK, Lee SI, et al. Mitochondrial NADH Dehydrogenase Subunit 3 (MTND3) Polymorphisms are Associated with Gastric Cancer Susceptibility[J]. Int J Med Sci, 2018, 15(12): 1329-1333. doi: 10.7150/ijms.26881
|
| [29] |
Cavalcante GC, Marinho ANR, Anaissi AK, et al. Whole mitochondrial genome sequencing highlights mitochondrial impact in gastric cancer[J]. Sci Rep, 2019, 9(1): 15716. doi: 10.1038/s41598-019-51951-x
|
| [30] |
Wallace LS, Mehrabi S, Bacanamwo M, et al. Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps[J]. Tumor Biol, 2016, 37(9): 12465-12475. doi: 10.1007/s13277-016-5101-3
|
| [31] |
Wallace LS, Cherian AM, Adamson P, et al. Comparison of Pre- and Post-translational Expressions of COXIV-1 and MT-ATPase 6 Genes in Colorectal Adenoma-Carcinoma Tissues[J]. J Carcinog Mutagen, 2018, 9(2): 319.
|
| [32] |
Wallace L, Mehrabi S, Bacanamwo M, et al. Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps [J]. Tumour Biol, 2016, 37(9): 12465-12475. doi: 10.1007/s13277-016-5101-3
|
| [33] |
Xu YC, Zhou JJ, Yuan Q, et al. Quantitative detection of circulating MT-ND1 as a potential biomarker for colorectal cancer[J]. Bosn J Basic Med Sci, 2021, 21(5): 577-586.
|
| [34] |
Lin CS, Liu LT, Ou LH, et al. Role of mitochondrial function in the invasiveness of human colon cancer cells[J]. Oncol Rep, 2018 39(1): 316-330.
|
| [35] |
Yang K, Li X, Forman MR, et al. Pre-diagnostic Leukocyte Mitochondrial DNA Copy Number and Colorectal Cancer Risk[J]. Carcinogenesis, 2019, 40(12): 1462-1468. doi: 10.1093/carcin/bgz159
|
| [36] |
Yuan Q, Su L, Wang T, et al. Mitochondrial DNA haplogroup M7 confers a reduced risk of colorectal cancer in a Han population from northern China[J]. J Cell Mol Med, 2021, 25(15): 7538-7544. doi: 10.1111/jcmm.16789
|
| [37] |
Guo Z, Zhao SN, Fan HY, et al. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for colon cancer[J]. Mitochondrial DNA A DNA Mapp Seq Anal, 2016, 27(6): 4244-4245.
|
| [38] |
Akouchekian M, Houshmand M, Akbari MH, et al. Analysis of mitochondrial ND1 gene in human colorectal cancer[J]. J Res Med Sci, 2011, 16(1): 50-55.
|
| [39] |
Kopinski PK, Singh LN, Zhang S, et al. Mitochondrial DNA variation and cancer[J]. Nat Rev Cancer. 2021, 21(7): 431-445. doi: 10.1038/s41568-021-00358-w
|
| [40] |
Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease[J]. Nat Rev Genet, 2005, 6(5): 389-402. doi: 10.1038/nrg1606
|
| [41] |
Li Q, Chen Q, Yang X, et al. Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive[J]. J Nanobiotechnology, 2022, 20(1): 84. doi: 10.1186/s12951-022-01241-y
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: